Chee Leok Goh – författare

Make real-time therapeutic decisions with confidence using this concise, authoritative guide to dermatologic conditions

Fitzpatrick's Therapeutics is a valuable bedside tool to assist clinicians in the treatment of dermatological conditions. It's the perfect companion to the larger Fitzpatrick's Dermatology, Ninth Edition. Concise yet thorough, Fitzpatrick's Therapeutics provides comprehensive treatment options in tabular format for the range of dermatologic conditions.

This accessible resource is filled with practical information for clinical practice, including dosing regimens, adverse effects, monitoring, and level of evidence based on the American Academy of Dermatology guidelines with annotated references.

Fitzpatrick's Therapeutics features:

A convenient tabular format for quick referenceConcise summaries of treatment options—topical, systemic, and proceduralInformation on treatment modifications and monitoringOverviews from leading experts on their therapeutic approaches to managing specific disease conditionsUpdated content on AccessDermatologyDxRx as new FDA-approved drugs become available

Make real-time therapeutic decisions with confidence with this concise, authoritative guide to dermatologic conditionsFitzpatrick''s Therapeutics is a valuable bedside tool to assist clinicians in the treatment of dermatological conditions. It''s the perfect companion to the larger Fitzpatrick''s Dermatology, Ninth Edition. Concise yet comprehensive, Fitzpatrick''s Therapeutics provides comprehensive treatment options in tabular format for the range of dermatologic conditions. You''ll find practical information for clinical practice, including dosing regimens, adverse effects, monitoring, and level of evidence based on the American Academy of Dermatology guidelines with annotated references.• Companion dermatologic treatment guide to Fitzpatrick''s Dermatology, Ninth Edition• Convenient tabular format for quick reference• Annotated references• Concise summaries of treatment options with information on treatment modifications and monitoring• Content will be updated on AccessDermatologyDxRx as new FDA-approved drugs become available

Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects.This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners.

Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects.This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners. 

Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects.This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners.

This book is the first authoritative and comprehensive volume dedicated to updates and current best practices in lasers in Dermatology. It provides an up-to-date and highly illustrated synopsis of the therapeutic applications, efficacy and safety of lasers to treat both medical and cosmetic dermatological conditions. Chapters will focus on newer advances and techniques in laser treatment for medical dermatological conditions such as keloids, viral warts and infantile haemangioma, and a wide range of cosmetic indications such as skin tightening, skin rejuvenation, skin resurfacing, pigmentation, and the removal of birthmarks, acquired melanocytic naevi, tattoos and unwanted hair. Updates on Lasers in Dermatology is a must-have resource for dermatologists, aesthetic GPs, and other medical physicians/specialists.

This book is the first authoritative and comprehensive volume dedicated to updates and current best practices in lasers in Dermatology. It provides an up-to-date and highly illustrated synopsis of the therapeutic applications, efficacy and safety of lasers to treat both medical and cosmetic dermatological conditions. Chapters will focus on newer advances and techniques in laser treatment for medical dermatological conditions such as keloids, viral warts and infantile haemangioma, and a wide range of cosmetic indications such as skin tightening, skin rejuvenation, skin resurfacing, pigmentation, and the removal of birthmarks, acquired melanocytic naevi, tattoos and unwanted hair. Updates on Lasers in Dermatology is a must-have resource for dermatologists, aesthetic GPs, and other medical physicians/specialists.

This invaluable textbook on contact and occupational skin diseases is written for dermatologists, occupational physicians and practitioners interested in dermatology who are working in the Asia-Pacific region. It consists of contributions from experts in contact and occupational dermatology from many parts of the region. While most other textbooks on this subject cater to Western practitioners, this book is unique in that it focuses on topics relevant to the Asia-Pacific region and the tropics, complementing the Western publications.There are differences in the epidemiology and clinical presentations of contact and occupational dermatitis in the Asia-Pacific countries and the tropics compared to the Western countries. This book addresses the epidemiology and the approaches to the topic in many Asia-Pacific countries. It is a simple practical guide to the principles and practice of managing patients with contact and occupational skin diseases. The editors have included many colour illustrations, to assist dermatologists and other practitioners in using the book more effectively. These illustrations have been painstakingly selected to bring out clinical features as succinctly as possible.